News
Why US-EU trade deal faces jeopardy over ambiguous pharmaceutical tariffs
Pharmaceutical companies are seeking clarification on tariffs imposed under the new US-EU trade agreement . Analysts caution that sector-specific punitive levies could jeopardise the entire deal, according to a CNBC report.
Stellantis said on Tuesday it faced greater headwinds this year including a 1.5-billion-euro impact from U.S. tariffs for ...
The U.S. stock market has shown relief the tariff rates aren’t as high as Trump initially threatened in April and hope for a ...
The 15% tariff would be lower than previously threatened, but it would remain a high duty on America’s largest trading ...
Higher tariffs, or import taxes, on European goods mean sellers in the U.S. would have to either increase prices for ...
The White House has confirmed that the 15% tariff agreed between the European Union and the United States includes pharmaceuticals and semiconductors.
The U.S. and the European Union announced a new trade agreement framework over the weekend, setting a 15% tariff on most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback